openPR Logo
Press release

Global Radiopharmaceuticals Market Report 2021: Emerging Trends, Business Growth Opportunities, Major Driving Factors

03-04-2021 07:37 AM CET | Health & Medicine

Press release from: The Business research company

Radiopharmaceuticals Market

Radiopharmaceuticals Market

New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact:
https://www.thebusinessresearchcompany.com/global-market-reports

The global radiopharmaceuticals market is expected to grow from $4.78 billion in 2020 to $5.12 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.75 billion in 2025 at a CAGR of 7%.

The Business Research Company offers Radiopharmaceuticals Global Market Report 2021" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3471

The radiopharmaceuticals market consists of sales of radiopharmaceuticals and related services by entities (organizations, sole traders, and partnerships) that produce radiopharmaceuticals used in treating cancer, cardiovascular, and other diseases. Radiopharmaceuticals are radioactive compounds administered to the patients, monitored via specific imaging devices, and used for diagnostic and therapeutic purposes.

Some of the key players involved in the Radiopharmaceuticals Market are Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging Inc.

The countries covered in the global Radiopharmaceuticals market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global Radiopharmaceuticals market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Radiopharmaceuticals Market Segmentation:
By Type
1. Diagnostic
2. Therapeutic

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/radiopharmaceuticals-global-market-report-2020-30-covid-19-growth-and-change

A Few Points From The Table Of Contents
1.Executive Summary
2.Report Structure
3.Radiopharmaceuticals Market Characteristics
4.Radiopharmaceuticals Market Product Analysis
5.Radiopharmaceuticals Market Supply Chain
……
21.Key Mergers And Acquisitions In The Radiopharmaceuticals Market
22.Radiopharmaceuticals Market Future Outlook and Potential Analysis
23.Recommendations
24.The Business Research Company
25.Copyright And Disclaimer

The report covers the trends and market dynamics of the Radiopharmaceuticals Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of this report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3471&type=smp

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow our blog: http://blog.tbrc.info/

About Us:
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Radiopharmaceuticals Market Report 2021: Emerging Trends, Business Growth Opportunities, Major Driving Factors here

News-ID: 2251897 • Views:

More Releases from The Business research company

Blood Meal Market Surges: Reaches $2.06 Billion in 2024, Set to Grow to $2.37 Billion by 2028 at 3.6% CAGR, Driven by Growing Aquaculture Industry
Blood Meal Market Surges: Reaches $2.06 Billion in 2024, Set to Grow to $2.37 Bi …
The blood meal market size has grown steadily in recent years. It will grow from $1.98 billion in 2023 to $2.06 billion in 2024 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to animal feed industry growth, meat and poultry production expansion, effective nutrient source, waste utilization in abattoirs, organic fertilizer production. The blood meal market size is expected to see
Beef Fat Market Growth Surges: Reaches $45.35 Billion in 2024, Set to Reach $61.59 Billion by 2028 with 8.0% CAGR
Beef Fat Market Growth Surges: Reaches $45.35 Billion in 2024, Set to Reach $61. …
The beef fat market size has grown strongly in recent years. It will grow from $42.17 billion in 2023 to $45.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increased livestock production trends, regulatory environment, health and nutritional trends, economic factors. The beef fat market size is expected to see strong growth in the next few years.
Antiviral Combination Therapy Market Surges: Reaches $54.5 Billion in 2024, Set for $71.16 Billion in 2028, CAGR 6.9%
Antiviral Combination Therapy Market Surges: Reaches $54.5 Billion in 2024, Set …
The antiviral combination therapy market size has grown strongly in recent years. It will grow from $51.15 billion in 2023 to $54.5 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to risen viral infections, patient preference for combination treatments, emergence of drug resistance, advancements in virology and immunology, global healthcare initiatives. The antiviral combination therapy market size is
Aluminum Composite Panels Market on Upward Trajectory: Expected to Reach $8.83B in 2028, CAGR 7.4%, Propelled by Construction Demand
Aluminum Composite Panels Market on Upward Trajectory: Expected to Reach $8.83B …
The aluminum composite panels market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.62 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to architectural growth and modern construction trends, increasing urbanization and infrastructure development, durability and weather resistance, versatility in design and aesthetic appeal, cost-effectiveness and material efficiency. The aluminum

All 5 Releases


More Releases for Radiopharmaceuticals

Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029 The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029. Gets a Sample Copy of the Nuclear
Diagnostic Radiopharmaceuticals Market 2021 | Detailed Report
According to Market Study Report, Diagnostic Radiopharmaceuticals Market provides a comprehensive analysis of the Diagnostic Radiopharmaceuticals Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Diagnostic Radiopharmaceuticals Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645020 The report provides a comprehensive analysis of
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a